Mooren ulcer

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:519408H16.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mooren ulcer is a rare, chronic, painful, progressive ulcerative condition of the cornea (the clear front surface of the eye). It is characterized by peripheral corneal ulceration that typically begins at the limbus (the border between the cornea and the white of the eye) and progresses circumferentially and then centrally, potentially leading to severe vision loss or even perforation of the cornea. The ulcer is idiopathic but is believed to involve an autoimmune mechanism in which the body's immune system attacks corneal stromal proteins. Mooren ulcer is distinguished from other causes of peripheral ulcerative keratitis by the absence of associated systemic autoimmune or infectious disease. Two clinical subtypes are generally recognized. The first is a unilateral, limited form that tends to occur in older adults and responds relatively well to treatment. The second is a bilateral, aggressive form that is more common in younger patients, particularly in certain populations in sub-Saharan Africa and the Indian subcontinent, and is more resistant to therapy. Symptoms include severe eye pain, tearing, redness, photophobia (light sensitivity), and progressive visual impairment. The ulceration can lead to corneal thinning, descemetocele formation, and perforation if untreated. Treatment of Mooren ulcer is challenging and often requires a stepwise approach. Initial management may include topical corticosteroids and cyclosporine to suppress local inflammation. Surgical interventions such as conjunctival resection or excision of the limbal conjunctiva adjacent to the ulcer can be effective, particularly in the limited form. In refractory or aggressive cases, systemic immunosuppressive agents such as methotrexate, cyclophosphamide, or mycophenolate mofetil may be necessary. Corneal grafting (keratoplasty) may be required for perforation or severe thinning, though recurrence in the graft is possible. Despite treatment, the prognosis for the aggressive bilateral form remains guarded.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mooren ulcer.

View clinical trials →

No actively recruiting trials found for Mooren ulcer at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mooren ulcer community →

No specialists are currently listed for Mooren ulcer.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mooren ulcer.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mooren ulcerForum →

No community posts yet. Be the first to share your experience with Mooren ulcer.

Start the conversation →

Latest news about Mooren ulcer

No recent news articles for Mooren ulcer.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mooren ulcer

What is Mooren ulcer?

Mooren ulcer is a rare, chronic, painful, progressive ulcerative condition of the cornea (the clear front surface of the eye). It is characterized by peripheral corneal ulceration that typically begins at the limbus (the border between the cornea and the white of the eye) and progresses circumferentially and then centrally, potentially leading to severe vision loss or even perforation of the cornea. The ulcer is idiopathic but is believed to involve an autoimmune mechanism in which the body's immune system attacks corneal stromal proteins. Mooren ulcer is distinguished from other causes of per